Basic Information
| LncRNA/CircRNA Name | FEZF1-AS1 |
| Synonyms | NR_036484 |
| Region | GRCh38_7:122303658-122310077 |
| Ensemble | ENSG00000230316 |
| Refseq | NR_036484 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | serum samples |
| Expression Pattern | up-regulated |
| Function Description | Detection of serum FEZF1-AS1 and AFAP1-AS1 showed both of them were up-regulated in GC patients compared with the normal controls (p < 0.0001), and high serum expression levels were correlated with tumor size, tumor-node-metastasis (TNM) stage and lymph node metastasis. |
| Pubmed ID | 31785996 |
| Year | 2019 |
| Title | Circulatinglong Non-Coding RNA FEZF1-AS1 and AFAP1-AS2 Serve as Potential Diagnostic Biomarkers for Gastric Cancer |
External Links
| Links for FEZF1-AS1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |